COIIX
Price
$18.35
Change
-$0.02 (-0.11%)
Updated
Oct 17 closing price
Net Assets
342.86M
VINEX
Price
$20.43
Change
-$0.05 (-0.24%)
Updated
Oct 17 closing price
Net Assets
1.48B
Interact to see
Advertisement

COIIX vs VINEX

Header iconCOIIX vs VINEX Comparison
Open Charts COIIX vs VINEXBanner chart's image
Calvert International Opportunities I
Price$18.35
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets342.86M
Vanguard International Explorer I
Price$20.43
Change-$0.05 (-0.24%)
VolumeN/A
Net Assets1.48B
COIIX vs VINEX Comparison Chart in %
View a ticker or compare two or three
VS
COIIX vs. VINEX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COIIX is a Buy and VINEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VINEX has more cash in the bank: 1.48B vs. COIIX (343M). VINEX pays higher dividends than COIIX: VINEX (3.30) vs COIIX (2.82). COIIX was incepted earlier than VINEX: COIIX (18 years) vs VINEX (29 years). COIIX (1.09) is less costly to investors than VINEX (0.44). VINEX is a more actively managed with annual turnover of: 48.00 vs. COIIX (31.00). VINEX has a lower initial minimum investment than COIIX: VINEX (3000) vs COIIX (1000000). VINEX annual gain was more profitable for investors over the last year : 13.79 vs. COIIX (6.67). VINEX return over 5 years is better than : 16.62 vs. COIIX (10.38).
COIIXVINEXCOIIX / VINEX
Total Expense Ratio1.090.44248%
Annual Report Gross Expense Ratio1.090.44248%
Fund Existence18 years29 years-
Gain YTD12.97725.03152%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets343M1.48B23%
Annual Yield % from dividends2.823.3085%
Returns for 1 year6.6713.7948%
Returns for 3 years42.5451.8682%
Returns for 5 years10.3816.6262%
Returns for 10 years40.5317.76228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTOF0.100.02
+23.63%
Altamira Therapeutics Ltd.
AGESF66.80N/A
N/A
ageas SA/NV
ABTZY5.22N/A
N/A
Aboitiz Equity Ventures, Inc.
GFGSF0.12N/A
-2.70%
GFG Resources Inc.
FAVO2.75-1.47
-34.90%
Favo Capital, Inc.